Lymphoma Rounds: Washington DC

DATE: Thursday, October 10, 2024 (note date change)
TIME: Networking 6:00 PM – 7:00 PM ET
Program 7:00 PM – 8:30 PM ET

LOCATION: Westin Arlington
801 N Glebe Road
Arlington, VA 22203

This program is free for healthcare professionals; however, pre-registration is required.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please email the Lymphoma Research Foundation at professionaleducation@lymphoma.org. Exhibit opportunities are available.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing professionaleducation@lymphoma.org at least one week before the program to confirm their attendance.

PROGRAM AGENDA

Program Agenda – Click here

EBV-Positive Lymphoproliferation in an Immunocompetent Patient
Mycal Casey, DO, Medstar Washington
Aarthi Shenoy, MD, Medstar Washington

Combination Targeted Therapy in Treatment-Naïve and Relapsed/Refractory Mantle Cell Lymphoma
Christopher Melani, MD, NCI/NIH
Mark Roschewski, MD, NCI/NIH

Alk Negative Anaplastic Large Cell Lymphoma in a Female AYA Patient
Paige Kube, DO, Children’s National Hospital
Birte Wistinghausen, MD, Children’s National Hospital

ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.

At the conclusion of this educational activity, the participant should be better able to:

• Summarize the latest developments in lymphoma diagnosis, treatment and management.
• Apply best practices for treating lymphoma patients.
• Inform patients about potential clinical trial opportunities.
• Establish a network of health care professionals who work with lymphoma patients.

This is the first program in the 2024-25 Washington DC Rounds series.

Washington DC Lymphoma Rounds Steering Committee

MedStar Georgetown University Hospital
Kieron Dunleavy, MD (chair)
Children’s National
Birte Wistinghausen, MD
MedStar Washington Hospital Center
Aarthi Shenoy, MD
National Cancer Institute/NIH
Mark Roschewski, MD
Rahul Lakhotia, MD
University of Virginia Cancer Center
Craig Portell, MD
Virginia Commonwealth University
Victor Yazbeck, MD

Physician Accreditation Statement

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and the Lymphoma Research Foundation. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.

Credit Statement

Purdue University College of Pharmacy designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provided by:
Lymphoma Research Foundation and the Purdue University College of Pharmacy